The other issue this brings up is that for a partner to benefit, they would be better off buying a stake in the entire company (all indications) Otherwise, every condition that leronlimab is used to treat like CAD will benefit, protect, and eat into the market share of another like alzheimer's or cancer.

Another is that people looking to protect their health will do what they can including exaggerate to their doctors to get access to the drug. Who doesn't want insurance against CAD, cancer, Alzheimers and stroke.